Ryan White Care Hepatitis C & B Language
NATAP Webinars:
Management of Persons Living with HIV Review 2025
Fri, Nov 21, 2025 12:30 PM EDT
Click Here to Register !
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
Combined use of ibalizumab and lenacapavir for the treatment of multidrug-resistant HIV-1: A case series Open Access
- (11/04/25)
ID Week:
PREFER-LA: People with HIV (PWH) in the United States with Prior Adherence Challenges with Oral Antiretroviral Therapy (ART) Prefer Cabotegravir + Rilpivirine Long-Acting (CAB+RPV LA) Therapy After Switch
- (11/04/25)
EACS:
Real-world implementation of long-acting injectable cabotegravir and rilpivirine: healthcare providers' perspectives and experiences
- (11/04/25)
EACS:
The Power of Choice: Perspectives From Healthcare Providers on Early Switch to CAB + RPV LA After Rapid Suppression With DTG/3TC
- (11/04/25)
EACS:
Healthcare Utilization and Costs in People Living with HIV With and Without Hypertension and Type 2 Diabetes Mellitus in the United States
- (11/04/25)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
ID Week:
Influence of Nucleos(t)ide Analogue Use With Bulevirtide on Treatment Outcomes in Chronic Hepatitis Delta
- (11/04/25)
More Hep D Articles...
Aging & Perinatally Acquired HIV
EACS:
High Risk of Renal Complications After Type 2 Diabetes Mellitus Diagnosis in People with HIV Compared with People Without HIV: Findings From the Cohort Study on Morbidity and HIV in Sweden (COSMOHS)
- (11/04/25)
EACS:
Addressing cognitive symptoms in people with HIV: Outcomes from a holistic screening and management pathway
- (11/04/25)
EACS:
USE OF PCSK9 INHIBITOR EVOLOCUMAB IN PLWH WITH PERSISTENT HYPERLIPIDEMIA DESPITE STATIN THERAPY: TWO CASE REPORTS
- (11/04/25)
EACS:
A Comparative Analysis of Echocardiographic Findings in People Living With HIV and Healthy Volunteers
- (11/04/25)
EACS:
Bempedoic acid and evolocumab use in [older] people living with HIV [multimorbodity]: A real-world snapshot of lipid-lowering strategies in statin-intolerant or reluctant individuals
- (11/04/25)
EACS:
Are we implementing statin initiation following the REPRIEVE Trial: Results of a clinical audit at an urban sexual health clinic in Sydney, Australia
- (11/04/25)
EACS:
Are we implementing statin initiation following the REPRIEVE Trial: Results of a clinical audit at an urban sexual health clinic in Sydney, Australia
- (11/04/25)
More Aging & HIV Articles...
PrEP
ID Week:
Real-World Persistence to Long-Acting Cabotegravir Versus Oral PrEP for HIV Prevention in Participants Using a Digital Health Companion Tool (AURORA Study)
- (11/04/25)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
ID Week:
Rapid Point-of-Care Hepatitis C RNA Test-to-Treat in Persons Experiencing Homelessness through Street Based Initiatives in Detroit, Michigan
- (11/04/25)
ID Week:
Low Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients in a Mobile and Telehealth HCV Elimination Program
- (11/04/25)
ID Week:
Hepatitis C virus treatment during pregnancy using glecaprevir/pibrentasvir
- (11/04/25)
ID Week:
Safety, Tolerability, and Outcomes of SofosbuviR/Velpatasvir in Treatment of Chronic Hepatitis C Virus during Pregnancy: Interim results from the STORC study
- (11/04/25)
ID Week:
Hepatitis C treatment during pregnancy Implementation of a shared decision-making care model
- (11/04/25)
ID Week:
Integrated Obstetric and Addiction Care Promotes Antepartum STI Screening and Poses Opportunities for Preventing the Vertical Transmission of HIV, HCV, and Syphilis
- (11/04/25)
ID Week:
Hepatitis C Virus Care Continuum Among People Who Inject Drugs
- (11/04/25)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
EASL:
A marker of cccDNA transcription - hepatitis B core-related antigen (HBcrAg) - mimics HBV RNA decline during antiviral therapy with bulevirtide in chronic hepatitis delta (HDV) patients
- (05/20/25)
EASL:
EASL Clinical Practice Guidelines Hepatitis B
- (05/21/25)
EASL:
Next generation hepatitis B virus antisense oligonucleotides incorporating novel chemistries demonstrated significantly improved properties compared to current clinical candidates
- (05/21/25)
More Hep B Articles...
Fatty Liver, NAFLD, NASH
ID Week:
The Association of Steatotic Liver Disease [fatty liver] and Cardiovascular Disease Risk in a Large Cohort of People with Human Immunodeficiency Virus
- (10/31/25)
Is coming off semaglutide slowly the key to preventing weight regain?
- (06/02/25)
Lifestyle modification (diet) programme for people living with HIV with metabolic dysfunction-associated steatotic liver disease: a randomised controlled trial
- (06/02/25)
EASL:
Semaglutide-treated participants in the phase 3 ESSENCE trial (part 1) have greater concordance of non-invasive test improvements compared with placebo
- (05/19/25)
EASL:
Exercise partly protects against semaglutide-induced muscle loss in obese LDLR-/-.Leiden mice
- (05/19/25)
EASL:
Efimosfermin Alfa Once-Monthly Treatment Improves Collagen Biomarker Profiles and Rapidly Induces Histological Fibrosis Regression in Subjects with MASH Stage F2-F3 Fibrosis in a 24-week Phase 2 Trial
- (05/19/25)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
https://academicmedicaleducation.com/meeting/2nd-african-workshop-women-hiv-2025
https://academicmedicaleducation.com/meeting/2nd-menopause-hiv-webinar-2025
https://www.croiconference.org
https://academicmedicaleducation.com/meeting/15th-international-workshop-women-hiv-2025
https://acthiv.org/
https://ddw.org/
https://www.easlcongress.eu/
https://asm.org/Events/ASM-Microbe/Home
IAS 2025, the 13th IAS Conference on HIV Science,
Kigali, Rwanda, July 13 to 17,
pre-conferences on 13 July.
https://www.iasociety.org/conferences/ias2025
https://academicmedicaleducation.com/meeting/26th-international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs
https://academicmedicaleducation.com/meeting/11th-international-viral-hepatitis-elimination-meeting-ivhem-2025
https://academicmedicaleducation.com/meeting/8th-conference-liver-disease-africa-colda-2025
https://www.eacsociety.org/european-aids-conference/european-aids-conference/
https://idweek.org/
https://academicmedicaleducation.com/meeting/16th-international-workshop-hiv-aging-2025
https://www.aasld.org/the-liver-meeting
https://neurohiv.com/
